Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...
582 studies found for:    Spasticity
Show Display Options
Rank Status Study
21 Completed Study of Nighttime Dosing of Sublingual Tizanidine (12 mg) in Multiple Sclerosis (MS) Patients With Significant Spasticity
Condition: Muscle Spasticity
Intervention: Drug: Tizanidine (sublingual or oral)
22 Completed
Has Results
Safety and Efficacy of Oral Fampridine-SR for the Treatment of Spasticity Resulting From Spinal Cord Injury
Conditions: Spinal Cord Injury;   Muscle Spasticity
Interventions: Drug: Fampridine-SR;   Other: Placebo
23 Recruiting The Effects of Cannabis on Dystonia and Spasticity on Pediatric Patients
Conditions: Spasticity;   Dystonia
Interventions: Drug: Avidekel oil;   Drug: Enriched Avidekel oil
24 Completed Oral Baclofen Pharmacokinetics and Pharmacodynamics in Children With Spasticity
Conditions: Spasticity;   Cerebral Palsy
Intervention: Drug: baclofen
25 Completed SISTERS: Spasticity In Stroke Study - Randomized Study
Condition: Severe Spasticity
Intervention: Drug: intrathecal baclofen
26 Completed
Has Results
Safety and Efficacy of Oral Fampridine-Sustained Release (SR) for the Treatment of Spasticity Resulting From Spinal Cord Injury
Conditions: Spinal Cord Injury;   Muscle Spasticity
Interventions: Drug: Fampridine-SR;   Drug: Placebo
27 Not yet recruiting Lateral Cord Stimulation as a New Treatment for Refractory Spastic Cerebral Palsy
Conditions: Cerebral Palsy;   Spasticity
Intervention: Device: Lateral spinal cord surgical implant of electrodes
28 Completed Trial Comparing Two Commercial Formulations of Botulinum Toxin Type A in the Treatment of Spasticity
Condition: Spasticity
Interventions: Drug: Botulinum toxin type A from laboratory Lanzhou;   Drug: Botulinum toxin type A from laboratory Allergan
29 Terminated Energy Costs of Spasticity in Spinal Cord Injury: A Pilot Investigation
Conditions: Basal Energy Expenditure;   Spasticity
Intervention: Other: Weaning of Antispasticity Medication
30 Active, not recruiting Optical Stimulation in Peripheral Nerves for Select Rhizotomy Procedures
Condition: Spasticity
Intervention: Procedure: Rhizotomy for children with spasticity
31 Completed One Year, Open Label, Dose Escalation Long-term Safety Study in Multiple Sclerosis (MS) Subjects With Spasticity
Conditions: Multiple Sclerosis;   Spasticity
Intervention: Drug: arbaclofen
32 Active, not recruiting The Effects of tDCS Combined With Balance Training on Lower Limbs Spasticity in Chronic Stroke Patients
Condition: Ischemic Stroke
Interventions: Device: Transcranial direct current stimulation (tDCS);   Device: Sham tDCS
33 Completed Prevalence of Spasticity in Adults With Mental Retardation Living in the Community
Conditions: Mental Retardation;   Spasticity
Intervention:
34 Withdrawn Spasticity Registry Evaluating Epidemiology, Treatment Patterns and Clinical Needs
Condition: Muscle Spasticity
Intervention: Other: No Intervention
35 Terminated Botox vs. Baclofen for Upper Limb Spasticity
Condition: Spasticity
Intervention: Drug: intramuscular Botox versus oral baclofen
36 Completed Shockwaves Therapy and Botulinum Toxin for the Treatment of Spasticity in Patients With Cerebral Palsy. A Cross Over RCT
Conditions: Spasticity;   Cerebral Palsy
Interventions: Device: shock waves;   Drug: Botulinum Toxin Type A
37 Completed MEDITOXIN® Versus BOTOX® in the Treatment of Post-stroke Spasticity of the Upper Limb Spasticity
Condition: Spasticity
Interventions: Drug: Botulinum toxin type A;   Drug: Botulinum Toxin type A
38 Active, not recruiting RELIEF Study: Lower Limb Pain Relief After Injection Cycles in Adults Suffering From Lower Limb Spasticity Following Stroke
Condition: Lower Limb Spasticity
Intervention: Drug: Botulinum Toxin Type A (BoNT-A) Injection
39 Completed Dose-response Study of Efficacy and Safety of Botulinum Toxin Type A to Treat Spasticity of the Leg(s) in Cerebral Palsy
Condition: Lower Limb Spasticity Due to Cerebral Palsy
Interventions: Drug: IncobotulinumtoxinA (16 Units per kg body weight);   Drug: IncobotulinumtoxinA (12 Units per kg body weight);   Drug: IncobotulinumtoxinA (4 Units per kg body weight)
40 Recruiting Study of the Effects on Motor Recovery of Early Post-stroke Spasticity Treatment
Condition: Muscle Spasticity
Interventions: Drug: botulinum A toxin;   Drug: Baclofen;   Drug: Placebo toxin;   Drug: placebo baclofen

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.